disappointments in the Dec'20 quarter results of peers with high in-home consumption, NEST's 10.1% domestic sales growth was healthy. This means that barring the COVID-led lockdown affected earnings in the Jun'20 quarter, domestic sales growth has been healthy for the rest of CY20. While gross profit was in line, there was a miss at the EBITDA and PAT level, largely attributed to higher marketing costs in 4QCY20 (as per its press release). This is actually a positive going forward as it indicates the management's confidence in its growth prospects. NEST doesn't disclose...